Literature DB >> 19631788

The frameless copper IUD (GyneFix) and the TCu380A IUD: results of an 8-year multicenter randomized comparative trial.

Olav Meirik1, Patrick J Rowe, Alexandre Peregoudov, Gilda Piaggio, Max Petzold.   

Abstract

BACKGROUND: Clinical performance of the frameless copper IUD (GyneFix), designed to reduce side effects related to the frame of conventional IUDs, and TCu380A was compared. STUDY
DESIGN: Randomized Multicenter randomized comparative trial. Parous women requesting and eligible to use IUD were admitted in 21 centers in eight countries in 1989-1993 and followed-up for up to 8 years.
RESULTS: Two thousand twenty-seven women were randomized to the frameless IUD and 2036 to TCu380A; 43 insertions of the frameless IUD failed and none for TCu380A. First-year expulsion rate of the frameless IUD was 5.3 (95% CI: 4.4-6.4) per 100 and 2.5 (95% CI: 1.9-3.3) for the TCu380A; second- through eighth-year expulsion rates were not different. First-year pregnancy rates for the frameless IUD and TCu380A were 1.3 (95% CI: 0.9-2.0) and 0.5 (95% CI: 0.3-0.9), respectively; second- through eighth-year cumulative pregnancy rates were 1.2 (95% CI: 0.7-1.9) and 2.5 (95% CI: 1.8-3.4), respectively. The 8-year cumulative rates of ectopic pregnancy and IUD removal for pain were lower for the frameless IUD than for TCu380A. Removals for other reasons were not different.
CONCLUSIONS: The frameless IUD had more insertion failures, expulsions and pregnancies in the first year than TCu380A, but fewer pregnancies from the second through the eighth year, and by 8 years had fewer ectopic pregnancies and removals for pain.

Entities:  

Mesh:

Year:  2009        PMID: 19631788     DOI: 10.1016/j.contraception.2009.02.006

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  4 in total

Review 1.  New developments in long-acting reversible contraception: the promise of intrauterine devices and implants to improve family planning services.

Authors:  David K Turok; Lori M Gawron; Samantha Lawson
Journal:  Fertil Steril       Date:  2016-10-04       Impact factor: 7.329

2.  Long-term safety, efficacy, and patient acceptability of the intrauterine Copper T-380A contraceptive device.

Authors:  Bliss Kaneshiro; Tod Aeby
Journal:  Int J Womens Health       Date:  2010-08-09

3.  Safety and efficacy in parous women of a 52-mg levonorgestrel-medicated intrauterine device: a 7-year randomized comparative study with the TCu380A.

Authors:  Patrick Rowe; Tim Farley; Alexandre Peregoudov; Gilda Piaggio; Simone Boccard; Sihem Landoulsi; Olav Meirik
Journal:  Contraception       Date:  2016-02-23       Impact factor: 3.375

4.  New intrauterine technologies for contraception and treatment in -nulliparous/adolescent and parous women.

Authors:  D Wildemeersch
Journal:  Facts Views Vis Obgyn       Date:  2009
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.